RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- EBITDA, 2025
- −$192M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$192M | — |
| 2024 | −$265M | — |
| 2023 | −$183M | — |
| 2022 | −$178M | — |
| 2021 | −$169M | — |
| 2020 | −$136M | — |
| 2019 | −$145M | — |
| 2018 | −$78M | — |
| 2017 | −$32M | — |
| 2016 | −$26M | — |